The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

42 articles for FG Salituro


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.EBI
Vertex Pharmaceuticals
Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo.EBI
TBA
The Discovery of VX-745: A Novel and Selective p38a Kinase Inhibitor.EBI
TBA
2-Aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of JAK2.EBI
Vertex Pharmaceuticals
A novel chemotype of kinase inhibitors: Discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitors.EBI
Vertex Pharmaceuticals
Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindole.EBI
Vertex Pharmaceuticals
 
Design, synthesis and molecular modeling of 3-acylamino-2- Carboxyindole NMDA receptor glycine-site antagonistsEBI
TBA
Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK).EBI
Vertex Pharmaceuticals
Breakthroughs in neuroactive steroid drug discovery.EBI
Sage Therapeutics
SAGE-718: A First-in-Class EBI
Sage Therapeutics
Impact of Allosteric Modulation in Drug Discovery: Innovation in Emerging Chemical Modalities.EBI
Therapeutics
Neuroactive Steroid EBI
Sage Therapeutics
Design and synthesis of novel conformationally restricted HIV protease inhibitors.EBI
Vertex Pharmaceuticals
Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitors.EBI
Vertex Pharmaceuticals
Multisubstrate inhibition of 4-hydroxybenzoate 3-monooxygenase.EBI
Marion Merrell Dow Research Institute
Synthesis of analogues of pepstatin. Effect of structure in subsites P1', P2', and P2 on inhibition of porcine pepsin.EBI
TBA
Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers.EBI
Agios Pharmaceuticals
Synthetic and enzyme inhibition studies of pepstatin analogues containing hydroxyethylene and ketomethylene dipeptide isosteres.EBI
TBA
Inhibition of aspartic proteinases by peptides containing lysine and ornithine side-chain analogues of statine.EBI
TBA
Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)EBI
Sage Therapeutics
3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site.EBI
Marion Merrell Dow Research Institute
COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONSBDB
TheRas
Acyl sulfonamides for treating cancerBDB
Bayer Aktiengesellschaft
METHODS FOR TREATMENT OF CANCERBDB
Frontier Medicines
PRMT5 INHIBITORS AND METHODS OF TREATMENTBDB
Hangzhou Unogen Biotech
Substituted benzamides as RIPK2 inhibitors for treatment of inflammatory bowel diseaseBDB
Boehringer Ingelheim International
THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDSBDB
Terns Pharmaceuticals
Compounds and pharmaceutical uses thereofBDB
SyneuRx International (Taiwan)
LRRK2 inhibitorsBDB
H. Lundbeck
Bicyclic amide compounds and methods of use thereofBDB
Genentech
Tetrahydroisoquinoline derivatives, preparation process and use thereofBDB
Sichuan Kelun-Biotech Biopharmaceutical
Use of aminomethylenecyclohexane-1,3-dione compoundBDB
Wigen Biomedicine Technology (Shanghai)
N2,N4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancerBDB
Korea Research Institute of Chemical Technology
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitorsBDB
Ideaya Bioscience
Substituted benzamides as RIPK2 inhibitorsBDB
Boehringer Ingelheim International
Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeuticsBDB
Stingray Therapeutics
Amino pyrimidine compound for inhibiting protein tyrosine kinase activityBDB
Shenzhen Targetrx
Cardiac glycoside analogs and their use in methods for inhibition of viral infectionBDB
The John Hopkins University
BTK InhibitorsBDB
Merck Sharp & Dohme
Incontinence treatment methodsBDB
Ixaltis
PyridinonesBDB
Boehringer Ingelheim International
Substituted pyrazolo[1,5-a]pyrazines as mGluR5 receptor modulatorsBDB
Vanderbilt University